Patients with a high proportion of CD105+ renal CSCs often show tumor metastatic disease.178 It was reported that MVs released by CD105+ renal CSCs enhanced tumor angiogenesis.163 Lindoso et al.179 demonstrated that renal CSCs-derived EVs recruited bone marrow MSCs and participated in tumor matrix remodeling. This evidence concerns the gene ENG and metastatic neoplasm.